Clear cell sarcoma or Malignant melanoma of soft part - a rare entity
Abstract
Clear cell sarcoma is an extremely rare,
slow growing and aggressive soft tissue
sarcoma with melanocytic differentiation.
We report a case of recurrent clear cell
sarcoma treated at our Institute for its
rarity and need for appropriate diagnosis
and treatment. A 26 year old male presented
to our Institute with recurrent
swelling in the right popliteal fossa for 1
month duration. He had previous excision
of the right popliteal fossa lesion
and reported as alveolar rhabdomyosarcoma
outside and he came to our Institute
for further treatment. On evaluation
he was diagnosed with non-metastatic
recurrent clear cell sarcoma of the right
popliteal fossa. He had right popliteal
fossa exploration and underwent right
above knee amputation in view of popliteal
vessel and nerve involvement. He
had an uneventful recovery and is receiving
ifosfamide and doxorubicin based adjuvant
chemotherapy. Clear cell sarcoma
is a rare melanin producing soft tissue
sarcoma with diagnostic challenge. Complete
surgical excision is
the optimal treatment for local control.
Keyword :Sarcoma, clear cell, melanoma
Full Text:
PDFReferences
Enzinger FM. 1965. Clear-Cell
Sarcoma of Tendons and Aponeuroses.
an Analysis of 21
Cases. Cancer 18:1163-74.
E. B. Chung and F. M. Enzinger,
“Malignant melanoma of soft parts.
A reassessment of clear cell sarcoma,”
American Journal of Surgical
Pathology, vol. 7, no. 5, pp. 405
–413, 1983.
A. Ferrari, M. Casanova, G. Bisogno
et al., “Clear cell sarcoma of
tendons and aponeuroses in pediatric
patients: a report from the Italian
and German Soft Tissue Sarcoma
Cooperative Group,” Cancer, vol.
, no. 12, pp. 3269–3276, 2002.
E. A. Montgomery, J. M. Meis, A.
G. Ramos et al. “Clear cell sarcoma
of tendons and aponeu-roses: a
clinicopathologic study of 58 cases
with analysis of prognostic factors,”
International Journal of Surgical Pathology,
vol. 1, pp. 89–100, 1993.
J. J. Eckardt, D. J. Pritchard, and
E. H. Soule, “Clear cell sarcoma. A
clinicopathologic study of 27 cases,”
Cancer, vol. 52, no. 8, pp. 1482–
, 1983.
Sara AS, Evans HL, and Benjamin
RS. 1990. Malignant Melanoma
of Soft Parts (Clear Cell Sarcoma):
A Study of 17 Cases, With Emphasis
on Prognostic Factors. Cancer
:367-374.
Bridge J, Sreekantaiah C, Neff J
et al. 1991. Cytogenetic findings in
clear cell sarcoma of tendons and
aponeuroses.
Malignant melanoma of soft
parts. Cancer genetics and cytogenetics
(1):101-6.
F. Picciotto, A. Zaccagna, G. Derosa et
al., “Clear cell sarcoma (malignant melanoma
of soft parts) and sentinel lymph
node biopsy,” European Journal of Dermatology,
vol. 15, no. 1, pp. 46–48,
Jones RL, Constantinidou A, Thway K
et al. 2010. Chemotherapy in clear cell
sarcoma. Medical oncology:859-863.
EORTC and Pfizer. 2012. Crosstumoral
Phase 2 Clinical Trial Exploring
Crizotinib (PF-02341066) in Patients
With Advanced Tumors Induced by
Causal Alterations of ALK and/or MET
("CREATE"). In: ClinicalTrials.gov
[Internet]. Bethesda (MD): National Library
of Medicine (US).
Liu S, Cheng H, and Kwan W. 2008.
Histone deacetylase inhibitors induce
growth arrest, apoptosis, and differentiation
in clear cell sarcoma models apoptosis,
and differentiation in clear cell sarcoma
models. Molecular Cancer Therapeutics:
-1761.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr MGR Medical University